ZLDPF — Zealand Pharma A/S/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2068427 ·
Denmark
Last close
$45.01
Market Cap
$3.14B
52W High
$55.36
52W Low
$38.50
ADV30
1,203
Next earnings
2026-05-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,000,000 | 34,000,000 | -539,000,000 | -394,000,000 | 15,301,000,000 | 3,849,000,000 | 832,000,000 |
| Dec 2025 | 68,915,000 | 68,915,000 | -356,544,000 | -379,115,000 | 15,948,798,000 | 4,576,541,000 | 1,118,185,000 |
| Sep 2025 | 49,569,000 | 49,569,000 | -461,320,000 | -404,233,000 | 16,797,246,000 | 5,972,711,000 | 1,634,645,000 |
| Jun 2025 | 9,088,284,000 | 9,087,874,000 | 8,338,423,000 | 7,573,697,000 | 17,180,064,000 | 7,244,047,000 | 1,571,270,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,531,933,000
Investing CF
$-2,248,506,000
Financing CF
$-378,182,000
CapEx
$-69,073,000
Dividends Paid
—
Buybacks
$-345,566,000
EPS Diluted TTM
$91.34
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$6,287,000
Inventory
$0
Receivables
—
ST Investments
$10,532,267,000
EBIT TTM
$7,030,122,000
Pretax Income TTM
$7,001,063,000
Interest Exp TTM
$29,059,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,240,859,648
EBITDA
$6,799,047,168
Free Cash Flow
$4,224,191,744
Enterprise Value
$-10,873,589,760
Total Cash
$14,467,999,744
Total Debt
$414,000,000
Shares Out
69,699,276
Trailing EPS
$13.94
Book Value
$32.52
ROE
56.2%
ROA
34.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,214,860,000 | 7,113,523,000 | 6,455,008,000 | 15,948,798,000 | 1,118,185,000 | — | 6,531,933,000 |
| Dec 2024 | 62,691,000 | -1,269,071,000 | -1,078,828,000 | 9,505,600,000 | 888,858,000 | — | -930,816,000 |
| Dec 2023 | 342,788,000 | -577,217,000 | -703,739,000 | 1,979,993,000 | 387,154,000 | — | -425,668,000 |
| Dec 2022 | 103,986,000 | -816,599,000 | -1,202,135,000 | 1,539,806,000 | 723,895,000 | — | -942,311,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.16
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RCWLY | Rockwool A/S/ADR | $3.12B | $32.00 | — |
| FLNC | Fluence Energy, Inc. | $3.11B | $23.42 | — |
| PUGBY | Puig Brands S.A./ADR | $3.18B | $9.35 | — |
| CALY | Callaway Golf Co | $3.09B | $17.20 | — |
| COHU | COHU INC | $3.09B | $65.45 | — |
News headlines (Yahoo Finance, 1h cache)
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Grow
2026-06-16 22:30 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
2026-06-15 15:00 · Yahoo
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
2026-06-10 20:00 · Yahoo
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
2026-06-08 16:34 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
2026-06-08 15:05 · Yahoo
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
2026-06-08 15:00 · Yahoo
Why The Narrative Around Zealand Pharma (CPSE:ZEAL) Is Shifting After Target Resets And Trial Updates
2026-06-08 06:11 · Yahoo
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in p
2026-06-07 18:30 · Yahoo
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people li
2026-06-05 20:45 · Yahoo
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
2026-06-02 15:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.